Collegium Pharmaceutical, Inc. Common Stock COLL
$28.26
+0.39%
at last close
Analyst Consensus
- Consensus Rating
- Buy (4 Buy · 1 Hold · 0 Sell)
- Average Price Target
- $50.60
- Implied Upside
- +79.1%
- Price Target Range
- $43.00 – $60.00
- Analysts (12 mo)
- 5
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-07 | Piper SandlerDavid Amsellem |
Reiterates | Neutral | $45 → $43 |
| 2026-08-06 | NeedhamSerge Belanger |
Maintains | Buy | $56 → $46 |
| 2026-03-20 | HC Wainwright & Co.Brandon Folkes |
Reiterates | Buy | $60 |
| 2026-03-19 | NeedhamSerge Belanger |
Reiterates | Buy | $54 → $56 |
| 2026-02-26 | NeedhamSerge Belanger |
Maintains | Buy | $56 → $54 |
| 2026-01-09 | BarclaysGlen Santangelo |
Maintains | Overweight | $58 → $56 |
| 2026-01-09 | HC Wainwright & Co.Brandon Folkes |
Reiterates | Buy | $46 → $60 |
| 2026-01-08 | NeedhamSerge Belanger |
Maintains | Buy | $48 → $56 |
| 2025-12-09 | BarclaysGlen Santangelo |
Initiates coverage on | Overweight | $58 |
| 2025-11-07 | Truist SecuritiesLes Sulewski |
Maintains | Buy | $45 → $48 |
| 2025-11-07 | HC Wainwright & Co.Brandon Folkes |
Maintains | Buy | $44 → $46 |
| 2025-10-28 | NeedhamSerge Belanger |
Reiterates | Buy | $46 |
| 2025-08-11 | HC Wainwright & Co.Brandon Folkes |
Assumes | Buy | $44 |
| 2025-05-09 | Piper SandlerDavid Amsellem |
Reiterates | Neutral | $36 → $37 |
| 2025-04-09 | NeedhamSerge Belanger |
Reiterates | Buy | $46 |
| 2025-03-24 | HC Wainwright & Co.Oren Livnat |
Reiterates | Buy | $50 |
| 2025-02-04 | Piper SandlerDavid Amsellem |
Maintains | Neutral | $37 → $36 |
| 2025-01-10 | NeedhamSerge Belanger |
Upgrades | Hold → Buy | $46 |
| 2025-01-10 | HC Wainwright & Co.Oren Livnat |
Reiterates | Buy | $50 |
| 2024-10-11 | Piper SandlerDavid Amsellem |
Reiterates | Neutral | $37 |
| 2024-09-05 | HC Wainwright & Co.Oren Livnat |
Maintains | Buy | $47 → $50 |
| 2024-08-09 | Piper SandlerDavid Amsellem |
Reiterates | Neutral | $39 → $37 |
| 2024-08-09 | Truist SecuritiesLes Sulewski |
Maintains | Buy | $40 → $42 |
| 2024-08-09 | NeedhamSerge Belanger |
Reiterates | Hold | — |
| 2024-07-30 | HC Wainwright & Co.Oren Livnat |
Upgrades | Neutral → Buy | $47 |
| 2024-07-30 | NeedhamSerge Belanger |
Reiterates | Hold | — |
| 2024-06-07 | JefferiesGlen Santangelo |
Upgrades | Hold → Buy | $41 → $44 |
| 2024-05-10 | NeedhamSerge Belanger |
Downgrades | Buy → Hold | — |
| 2024-05-10 | Piper SandlerDavid Amsellem |
Downgrades | Overweight → Neutral | $39 |
| 2024-04-11 | NeedhamSerge Belanger |
Reiterates | Buy | $40 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $28.26
- Market Cap
- $833.55 million
- 52-Week Range
- $25.47 – $50.79
- Average Volume
- 569K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.